WO2023037248 - IDENTIFICATION OF CHANGING PATHWAYS OR DISEASE INDICATORS THROUGH CLUSTER ANALYSIS
National phase entry:
Publication Number
WO/2023/037248
Publication Date
16.03.2023
International Application No.
PCT/IB2022/058384
International Filing Date
06.09.2022
Title **
[English]
IDENTIFICATION OF CHANGING PATHWAYS OR DISEASE INDICATORS THROUGH CLUSTER ANALYSIS
[French]
IDENTIFICATION DE VOIES DE CHANGEMENT OU D'INDICATEURS DE MALADIE PAR ANALYSE PAR GROUPE
Applicants **
DH TECHNOLOGIES DEVELOPMENT PTE. LTD.
33 Marsiling Industrial Estate Road 3,
#04-06
Singapore 739256, SG
Inventors
TATE, Stephen A.
71 Four Valley Drive
Concord, Ontario L4K 4V8, CA
Priority Data
63/260,975
08.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1296 | |
| EPO | Filing, Examination | 5071 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 10242 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
dimensions. Two clustering algorithms are applied to the measurements, producing two sets of clusters, and compounds in the sets are identified. Two or more compounds found in a cluster of both sets are identified. The two or more compounds are compared to groups of compounds related to a biological process to identify a group that includes the two or more compounds. An additional compound is selected from the group. The two sets are reanalyzed to identify the compound in the sets. A co-occurrence matrix is calculated that quantifies the co-occurrence of the compound and each of the two or more compounds in the sets. If no co-occurrence quantity for the compound and each of the two or more compounds in the matrix is below a threshold, the two or more compounds are verified.[French]
dimensions. Deux algorithmes de regroupement sont appliqués aux mesures, produisant deux ensembles de groupes, et des composés dans les ensembles sont identifiés. Au moins deux composés trouvés dans un groupe des deux ensembles sont identifiés. Les deux, ou plus, composés sont comparés à des groupes de composés liés à un processus biologique pour identifier un groupe qui comprend les deux, ou plus, composés. Un composé supplémentaire est sélectionné dans le groupe. Les deux ensembles sont analysés de nouveau pour identifier le composé dans les ensembles. Une matrice de cooccurrence est calculée. Elle quantifie la cooccurrence du composé et de chacun des deux, ou plus, composés dans les ensembles. Si aucune quantité de cooccurrence pour le composé et chacun des deux, ou plus, composés dans la matrice n'est inférieure à un seuil, les deux, ou plus, composés sont vérifiés.